NIPPON CHEMIPHAR CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,620 JPY | +0.62% |
|
+1.82% | +3.78% |
| 2023 | Delta-Fly Pharma, Inc. announced that it has received ¥503.7238 million in funding from Nippon Chemiphar Co., Ltd. | CI |
| 2023 | Global EV battery supply chain puzzles over China graphite curbs | RE |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 32.51B 210M | Sales 2023 | 31.56B 204M | Capitalization | 6.64B 42.94M |
|---|---|---|---|---|---|
| Net income 2022 | 700M 4.53M | Net income 2023 | 339M 2.19M | EV / Sales 2022 | 0.33 x |
| Net Debt 2022 | 3.14B 20.34M | Net Debt 2023 | 4.7B 30.42M | EV / Sales 2023 | 0.36 x |
| P/E ratio 2022 |
10.7
x | P/E ratio 2023 |
19.6
x | Employees | 872 |
| Yield 2022 |
2.4% | Yield 2023 |
2.72% | Free-Float | 48.25% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.62% | ||
| 1 week | +1.82% | ||
| Current month | +1.82% | ||
| 1 month | -0.67% | ||
| 3 months | +0.93% | ||
| 6 months | -0.92% | ||
| Current year | +3.78% |
1 week
1 592.00
1 627.00
1 month
1 590.001 647.00
Current year
1 577.001 700.00
1 year
1 550.002 112.00
3 years
1 550.003 250.00
5 years
1 550.004 005.00
10 years
1 550.008 130.00
| Managers | Title | Age | Since |
|---|---|---|---|
| President | 65 | 85-03-31 | |
Shinji Nakajima
ADM | Chief Administrative Officer | - | - |
| Chief Tech/Sci/R&D Officer | 56 | 05-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| President | 65 | 85-03-31 | |
Yuji Harada
BRD | Director/Board Member | 72 | 17-05-31 |
Haruki Mori
AUD | Comptroller/Controller/Auditor | 76 | 66-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 15 M€ | +10.53% | ||
| 0.00% | 18 M€ | +15.35% | - | |
| 0.00% | 66,066 M€ | +17.02% | - | |
| 0.00% | 144,586 M€ | +16.99% | ||
| 0.00% | 20,721 M€ | +15.87% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-06 | 1,620 | +0.62% | 500 |
| 24-05-02 | 1,610 | +0.62% | 1,800 |
| 24-05-01 | 1,600 | +0.57% | 2,400 |
Delayed Quote Japan Exchange, May 06, 2024 at 10:30 pm EDT
More quotes
NIPPON CHEMIPHAR CO., LTD. is a Japan-based company centered on ethical pharmaceutical products and mainly engaged in the pharmaceutical, health and beauty related businesses. The Companyâs Pharmaceutical segment is engaged in the manufacture and sale of ethical pharmaceutical products. Other businesses include entrusted safety testing, healthcare and real estate leasing business. The Company mainly operates in Japan and Vietnam.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +3.78% | 38.45M | |
| +31.52% | 662B | |
| +21.96% | 546B | |
| -5.21% | 359B | |
| +17.02% | 323B | |
| +5.01% | 289B | |
| +13.68% | 234B | |
| +3.81% | 198B | |
| -10.63% | 194B | |
| +3.98% | 167B |
- Stock Market
- Equities
- 4539 Stock